The hepatic growth factor (HGF) is a well-known antifibrotic factor, and its role to ameliorate fibrosis and inflammation has been reported in various experimental models of NASH [36–38]. The gene discussed is HGF; the disease is metabolic dysfunction-associated steatohepatitis.